bioAffinity Technologies ...

0.27
0.15 (124.81%)
At close: Apr 17, 2025, 3:14 PM

Company Description

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment.

The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.

The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

bioAffinity Technologies Inc.
bioAffinity Technologies Inc. logo
Country United States
IPO Date n/a
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 57
CEO Maria Zannes J.D.

Contact Details

Address:
No Address available
No city data available, Delaware
United States
Website http://www.bioaffinitytech.com

Stock Details

Ticker Symbol BIAFW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001712762
CUSIP Number 09076W117
ISIN Number US09076W1172
Employer ID 46-5211056
SIC Code 8731

Key Executives

Name Position
Maria Zannes J.D. Founder, President, Chief Executive Officer & Director
James Michael Edwards C.P.A., M.B.A. Chief Financial Officer & Principal Accounting Officer
Xavier T. Reveles M.S. Chief Operating Officer
Dallas J. Coleman Vice President of sales
Dr. William Bauta Ph.D. Chief Science Officer
Julie Anne Overton Director of Communications
Steven Girgenti Founder & Executive Chairman of the Board
Timothy P. Zannes J.D. Executive Vice President, Secretary & General Counsel

Latest SEC Filings

Date Type Title
Apr 15, 2025 PRE 14A Filing
Apr 14, 2025 8-K Current Report
Apr 11, 2025 S-1 Filing
Mar 31, 2025 10-K Annual Report
Mar 31, 2025 8-K Current Report
Mar 07, 2025 8-K Current Report
Feb 27, 2025 8-K Current Report
Feb 25, 2025 424B5 Filing
Feb 25, 2025 424B5 Filing
Feb 07, 2025 8-K Current Report